Implementation of a unique hepatitis C care continuum model in Rwanda

J Public Health (Oxf). 2019 Jun 1;41(2):e203-e208. doi: 10.1093/pubmed/fdy115.

Abstract

Background: There has been an evolution in the treatment of chronic hepatitis C (HCV) due to highly effective direct-acting antivirals, however, restriction of treatment to medical specialists hinders escalation of HCV treatment. This is particularly true in resource-limited settings (RLS), which disproportionately represent the burden of HCV worldwide. The ASCEND study in Washington, DC, demonstrated that complete task-shifting can safely and effectively overcome a low provider-to-patient ratio and expand HCV treatment. However, this model has not been applied internationally to RLS.

Method: The validated ASCEND model was translated to an international clinical program in Kigali, Rwanda, aimed at training general medicine providers on HCV management and obtaining HCV prevalence data.

Results: The didactic training program administered to 11 new HCV providers in Rwanda increased provider's knowledge about HCV management. Through the training program, 26% of patients seen during the follow-up period were screened for HCV and a prevalence estimate of 2% was ascertained. Of these patients, 30% were co-infected with hepatitis B.

Conclusion: The ASCEND paradigm can be successfully implemented in RLS to escalate HCV care, in a self-sustaining fashion that educates more providers about HCV management, while increasing the public's awareness of HCV and access to treatment.

Keywords: health promotion; infectious disease.

MeSH terms

  • Antiviral Agents / therapeutic use
  • Continuity of Patient Care / organization & administration*
  • Education / organization & administration
  • Female
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Male
  • Models, Organizational
  • Program Development
  • Rwanda

Substances

  • Antiviral Agents